Havas reported net organic revenue growth of 2.6% in the second quarter with first half growth of 2.3%.  

Total net revenue for the first half was 1.4 billion euros ($1.6 billion), up 3.1% from 2024.  

For now the company said it was sticking by its full-year guidance of achieving organic growth of “above 2.0%.”   

Asked on an earnings call with analysts if there was some concern about second half growth, company CEO Yannick Bollore replied that there was not. While the company is “confident” it will achieve the stated guidance, Bollore noted uncertain macroeconomic conditions as a reason for not upgrading the firm’s outlook at this time. 

The firm did not break out performance by levels but said that all major units including media, creative, direct marketing and healthcare marketing contributed to growth during Q2. Healthcare in particular rebounded after a client loss last year.  

By region, North America was strongest with 4.6% growth in the quarter. Europe was up 2.6% while the Asia Pacific and Africa regions combined were down 4.9% in part due to client losses.  

In North America, which accounted for 35% of net revenue in the period, growth in the first half (+3.9) was driven by a double-digit gain at Havas Health. By comparison, the region was down 6.4% during the first half of 2024.  

The company noted that it has rebranded its global strategy and operating system Converged to Converged.ai to amplify the positioning that AI is integrated throughout the platform. 

Havas Media wins in the first half included Olive Garden and Elizabeth Arden. Creative wins included Under Armour and Toyota and the health care unit won assignments from GSK and Merck among others.